The FDA chief has called into question whether the agency will approve and authorize the COVID-19 vaccine for winter. In August 2024, the U.S. Food and Drug Administration approved the updated ...

Even mild COVID-19 cases can trigger lingering symptoms, especially in women and younger adults, while severe cases show a strong link to long-term fatigue, brain fog, and joint pain, setting ...

and August Pfluger, R-Texas, will file the No Vaccine Mandates in Higher Education Act, chiefly noting that former President Joe Biden ended the official national emergency for COVID-19 in April 2023.

She serves on WHO's Immunization and Vaccines Related Implementation Research Advisory Committee (IVIR-AC) Five years ago, COVID was all we could think about. Today, we’d rather forget about ...

The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve COVID-19 vaccines for next winter, citing a lack of data on booster shots.

Five years ago, COVID was all we could think about. Today, we'd rather forget about lockdowns, testing lines and social distancing. But the virus that sparked the pandemic, SARS-CoV-2, is still ...

As China and the United States trade charges of a lab leak, researchers contend in a new paper that the Covid pandemic got its start, like a previous one, in the wildlife trade. By Carl Zimmer In ...

China pointed its finger at the United States for originating COVID-19 on Wednesday, claiming America was attempting to “shift the blame” after President Trump declared the deadly disease was ...

Understanding long COVID To dive deeper into the persistent respiratory symptoms of long COVID, Woodfolk and her team examined extensive clinical and immune datasets from 110 patients at UVA ...

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. In the deadly summer of 2020, Hispanics in Texas were half of all COVID ...

A clinical trial is underway to assess the effectiveness and safety of sipavibart, AstraZeneca's long-acting monoclonal antibody designed to provide protection against Covid-19, as a potential ...